Glycomics Market Synopsis

Glycomics Market Size Was Valued at USD 1.9 Billion in 2023, and is Projected to Reach USD 6.6 Billion by 2032, Growing at a CAGR of 14.6% From 2024-2032.

The glycomics market is the analysis of glycomes which are defined as all the glycan structures that an organism can produce. Glycomics refers to the study of glycan structures within biological systems and tries to reveal their functions in health and diseases. Others include this field involves identification, quantification as well as characterization of glycans or sugar moiety which is attached to proteins and lipids. Presently, it is an important area of study mainly concerning aspects of life, for instance cell communication, the immune system, and approaches to treatment including pharmacology. Due to rise in awareness in the personalized medicine and biotechnology sectors, the glycomics market has attracted much interst.

• The glycomics market has been evolving significantly over the years because of improved glycobiology study and more attention to glycan-based fields in pharmacy biotechnology companies. Owing to increased understanding of the multidimensionality of glycans and their involvement in various essential biological processes, the need to develop glycomics-associated tools, equipment, and solutions has risen. The market includes enzymes, instruments, reagents and analytical kits necessary for glycobiology studies, and it is a vast market. In addition, proteomics, genomics, and the discovery and growth of biomarkers have created the base for the glycomics sector to expand as one of the most important sectors for modern biomedical sciences.
• This has further created market growth through utilization of glycomics in disease diagnosis, development of therapeutics and in creating vaccines. Glycans play a pivotal role in the development of different diseases such as cancer, infection diseases and autoimmune diseases. As disease biomarkers and therapeutic targets, more research has been conducted in this area especially in the biopharmaceutical industry. Therefore, the growth in glycomics tools and technologies is being increasingly funded by companies over the years, which will further fuel growth in the coming years.

Glycomics Market Trend Analysis

Integration of AI and Big Data in Glycomics

• The most revolutionary change in the glycomics market is the advanced utilization of artificial intelligence big data analytics. The innate structural variability of glycans and their activity in rendering diverse biological functions implies the need for an elaborate analytical system to decipher their functions. Modern glycomics research is making use of artificial intelligence and big data platforms to process huge amounts of data collected. This leads to improved glycan identification, prediction of their structure, and functional analysis of glycans, which reduces the time and cost of work in the field of glycomics. Also, integration of AI is believed to improve the drug discovery in as far as glycans are concerned and therefore push the market forward.

Growing Focus on Personalized Medicine

• The rising importance of the concept of a personalized approach toward disease diagnosis and treatment is one of the chief opportunities for the glycomics business. Since glycans always directly or indirectly modulate individual biological responses to therapies, glycomics is an indispensable factor in the design of personalized therapies. In the light of distinct approaches towards individualized treatment being adopted within the healthcare field, glycomics research make significant input towards the development of disease-specific drugs and therapies depending on glycans. Cancer treatment and diagnosis are also areas where this shift is being applied, glycomics for development of biomarkers: tumor-specific glycans for early detection and therapies. With rising investment on Personalised Medicine, the glycomics market has been expected to gain a lot of traction.

Glycomics Market Segment Analysis:

Glycomics Market Segmented on the basis of type, application and end user.

By Type, Enzymes segment accounted for the largest market share of 28.8% in 2023

• However, enzymes segment emerged to be the largest in the glycomics market with a market share of 28.8% in the year 2022. Since enzymes help to analyze and modify glycan structures, they are a very important component in glycomics research. Glycosidases and glycosyltransferases are indispensable for degradation or construction of glycans, so the functions of glycans can be investigated in detail. One has to do with the growth in demand for enzymes in research and therapeutic aspects especially in drugs which has triggered the growth in this segment. In addition, enzyme based tools & reagents are found largely for glycomics research studies in both academic & industrial sectors that consequently strengthen the enzymes market in glycomics.

By Application, drug discovery & development segment expected to held the largest share

• It is predicted that, the drug discovery and development segment is largest among the glycomics market owing to the increasing application of glycans for new drug targets and disease profiles. Glycans play many roles in cell signaling, immunology, and pathogens, and are thus a useful platforms for the discovery of new drugs. The swallowed interest in glycans as therapeutic targets is reflected in the activities of pharmaceutical firms and research establishments, especially in fields such as oncology, infectious diseases and neurology. This segment will likely remain a dominant as more glycan related biomarkers and targets for drugs are discovered in the drug discovery process.

Glycomics Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• Geography, which includes North America accounted a larger portion of the global glycomics market owing to its first-world healthcare, advanced research organizations, and high research spending on biotechnology & pharmaceuticals. The US remained the highest investing country in the region, due to constant glycomics research and advanced tools and technologies. This region is people by major biotechnology companies and research organisations in the glycomics field which has propelled market growth. The market share in North America is expected to be around 38% in the year 2023 due to major funding towards research activity and increasing application of glycan based theranostics in healthcare.

Active Key Players in the Glycomics Market

• Agilent Technologies (USA)
• Asparia Glycomics (Spain)
• Bruker Corporation (USA)
• Danaher Corporation (USA)
• GlycoThera GmbH (Germany)
• Lectenz Bio (USA)
• Merck KGaA (Germany)
• New England Biolabs (USA)
• RayBiotech Life (USA)
• S-BIO (Japan)
• Shimadzu Corporation (Japan)
• Takara Bio (Japan)
• Thermo Fisher Scientific (USA)
• Waters Corporation (USA)
• Z Biotech (USA)
• Other Key Players                                                 

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Glycomics Market by Type
 4.1 Glycomics Market Snapshot and Growth Engine
 4.2 Glycomics Market Overview
 4.3 Enzymes
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Enzymes: Geographic Segmentation Analysis
 4.4 Kits
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Kits: Geographic Segmentation Analysis
 4.5 Reagents
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Reagents: Geographic Segmentation Analysis
 4.6 Instruments
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Instruments: Geographic Segmentation Analysis

Chapter 5: Glycomics Market by Application
 5.1 Glycomics Market Snapshot and Growth Engine
 5.2 Glycomics Market Overview
 5.3 Drug Discovery & Development
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Drug Discovery & Development: Geographic Segmentation Analysis
 5.4 Diagnostics
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Diagnostics: Geographic Segmentation Analysis
 5.5 Others
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Others: Geographic Segmentation Analysis

Chapter 6: Glycomics Market by End User
 6.1 Glycomics Market Snapshot and Growth Engine
 6.2 Glycomics Market Overview
 6.3 Academic & Research Institutes
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Academic & Research Institutes: Geographic Segmentation Analysis
 6.4 Pharmaceutical & Biotechnology Companies
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Pharmaceutical & Biotechnology Companies: Geographic Segmentation Analysis
 6.5 Biopharmaceutical Companies
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Biopharmaceutical Companies: Geographic Segmentation Analysis
 6.6 CROs
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 CROs: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 Glycomics Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions
  
 7.2 AGILENT TECHNOLOGIES (USA)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 ASPARIA GLYCOMICS (SPAIN)
 7.4 BRUKER CORPORATION (USA)
 7.5 DANAHER CORPORATION (USA)
 7.6 GLYCOTHERA GMBH (GERMANY)
 7.7 LECTENZ BIO (USA)
 7.8 MERCK KGAA (GERMANY)
 7.9 NEW ENGLAND BIOLABS (USA)
 7.10 RAYBIOTECH LIFE (USA)
 7.11 S-BIO (JAPAN)
 7.12 SHIMADZU CORPORATION (JAPAN)
 7.13 TAKARA BIO (JAPAN)
 7.14 THERMO FISHER SCIENTIFIC (USA)
 7.15 WATERS CORPORATION (USA)
 7.16 Z BIOTECH (USA)
 7.17 OTHER ACTIVE PLAYERS

Chapter 8: Global Glycomics Market By Region
 8.1 Overview
 8.2. North America Glycomics Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Type
  8.2.4.1 Enzymes
  8.2.4.2 Kits
  8.2.4.3 Reagents
  8.2.4.4 Instruments
  8.2.5 Historic and Forecasted Market Size By Application
  8.2.5.1 Drug Discovery & Development
  8.2.5.2 Diagnostics
  8.2.5.3 Others
  8.2.6 Historic and Forecasted Market Size By End User
  8.2.6.1 Academic & Research Institutes
  8.2.6.2 Pharmaceutical & Biotechnology Companies
  8.2.6.3 Biopharmaceutical Companies
  8.2.6.4 CROs
  8.2.7 Historic and Forecast Market Size by Country
  8.2.7.1 US
  8.2.7.2 Canada
  8.2.7.3 Mexico
 8.3. Eastern Europe Glycomics Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Type
  8.3.4.1 Enzymes
  8.3.4.2 Kits
  8.3.4.3 Reagents
  8.3.4.4 Instruments
  8.3.5 Historic and Forecasted Market Size By Application
  8.3.5.1 Drug Discovery & Development
  8.3.5.2 Diagnostics
  8.3.5.3 Others
  8.3.6 Historic and Forecasted Market Size By End User
  8.3.6.1 Academic & Research Institutes
  8.3.6.2 Pharmaceutical & Biotechnology Companies
  8.3.6.3 Biopharmaceutical Companies
  8.3.6.4 CROs
  8.3.7 Historic and Forecast Market Size by Country
  8.3.7.1 Bulgaria
  8.3.7.2 The Czech Republic
  8.3.7.3 Hungary
  8.3.7.4 Poland
  8.3.7.5 Romania
  8.3.7.6 Rest of Eastern Europe
 8.4. Western Europe Glycomics Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Type
  8.4.4.1 Enzymes
  8.4.4.2 Kits
  8.4.4.3 Reagents
  8.4.4.4 Instruments
  8.4.5 Historic and Forecasted Market Size By Application
  8.4.5.1 Drug Discovery & Development
  8.4.5.2 Diagnostics
  8.4.5.3 Others
  8.4.6 Historic and Forecasted Market Size By End User
  8.4.6.1 Academic & Research Institutes
  8.4.6.2 Pharmaceutical & Biotechnology Companies
  8.4.6.3 Biopharmaceutical Companies
  8.4.6.4 CROs
  8.4.7 Historic and Forecast Market Size by Country
  8.4.7.1 Germany
  8.4.7.2 UK
  8.4.7.3 France
  8.4.7.4 Netherlands
  8.4.7.5 Italy
  8.4.7.6 Russia
  8.4.7.7 Spain
  8.4.7.8 Rest of Western Europe
 8.5. Asia Pacific Glycomics Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Type
  8.5.4.1 Enzymes
  8.5.4.2 Kits
  8.5.4.3 Reagents
  8.5.4.4 Instruments
  8.5.5 Historic and Forecasted Market Size By Application
  8.5.5.1 Drug Discovery & Development
  8.5.5.2 Diagnostics
  8.5.5.3 Others
  8.5.6 Historic and Forecasted Market Size By End User
  8.5.6.1 Academic & Research Institutes
  8.5.6.2 Pharmaceutical & Biotechnology Companies
  8.5.6.3 Biopharmaceutical Companies
  8.5.6.4 CROs
  8.5.7 Historic and Forecast Market Size by Country
  8.5.7.1 China
  8.5.7.2 India
  8.5.7.3 Japan
  8.5.7.4 South Korea
  8.5.7.5 Malaysia
  8.5.7.6 Thailand
  8.5.7.7 Vietnam
  8.5.7.8 The Philippines
  8.5.7.9 Australia
  8.5.7.10 New Zealand
  8.5.7.11 Rest of APAC
 8.6. Middle East & Africa Glycomics Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Type
  8.6.4.1 Enzymes
  8.6.4.2 Kits
  8.6.4.3 Reagents
  8.6.4.4 Instruments
  8.6.5 Historic and Forecasted Market Size By Application
  8.6.5.1 Drug Discovery & Development
  8.6.5.2 Diagnostics
  8.6.5.3 Others
  8.6.6 Historic and Forecasted Market Size By End User
  8.6.6.1 Academic & Research Institutes
  8.6.6.2 Pharmaceutical & Biotechnology Companies
  8.6.6.3 Biopharmaceutical Companies
  8.6.6.4 CROs
  8.6.7 Historic and Forecast Market Size by Country
  8.6.7.1 Turkey
  8.6.7.2 Bahrain
  8.6.7.3 Kuwait
  8.6.7.4 Saudi Arabia
  8.6.7.5 Qatar
  8.6.7.6 UAE
  8.6.7.7 Israel
  8.6.7.8 South Africa
 8.7. South America Glycomics Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Type
  8.7.4.1 Enzymes
  8.7.4.2 Kits
  8.7.4.3 Reagents
  8.7.4.4 Instruments
  8.7.5 Historic and Forecasted Market Size By Application
  8.7.5.1 Drug Discovery & Development
  8.7.5.2 Diagnostics
  8.7.5.3 Others
  8.7.6 Historic and Forecasted Market Size By End User
  8.7.6.1 Academic & Research Institutes
  8.7.6.2 Pharmaceutical & Biotechnology Companies
  8.7.6.3 Biopharmaceutical Companies
  8.7.6.4 CROs
  8.7.7 Historic and Forecast Market Size by Country
  8.7.7.1 Brazil
  8.7.7.2 Argentina
  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research